Pharmacological inhibition of FGFR signaling also suppressed tumorigenesis, prevented MAPK signaling and downregulated the expression of the ETV4 and ETV5 transcription factors, which were overexpressed in human and mouse tumor samples. The gene discussed is ETV4; the disease is neoplasm.